Metabolic Effects of Fluoxetine in Adults with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Placebo-Controlled Trials
2011

Effects of Fluoxetine on Weight and Metabolism in Type 2 Diabetes

Sample size: 5 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ye Zi, Chen Lili, Yang Zhen, Li Qin, Huang Ying, He Min, Zhang Shuo, Zhang Zhaoyun, Wang Xuanchun, Zhao Weiwei, Hu Ji, Liu Chao, Qu Shen, Hu Renming

Primary Institution: Institute of Endocrinology and Diabetology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China

Hypothesis

This meta-analysis aims to assess the metabolic effects of fluoxetine in individuals with type 2 diabetes mellitus (T2DM).

Conclusion

Fluoxetine therapy can lead to weight loss and reductions in fasting plasma glucose, HbA1c, and triglycerides in individuals with T2DM.

Supporting Evidence

  • Fluoxetine therapy resulted in an average weight loss of 4.27 kg compared to placebo.
  • Fasting plasma glucose decreased by 1.41 mmol/L with fluoxetine treatment.
  • Triglyceride levels were reduced by 0.54 mmol/L in patients receiving fluoxetine.
  • HbA1c levels showed a decrement of 0.78% with fluoxetine, although not statistically significant.
  • The studies included were all randomized, placebo-controlled trials.

Takeaway

Fluoxetine can help people with type 2 diabetes lose weight and improve their blood sugar levels.

Methodology

A systematic review and meta-analysis of five randomized, placebo-controlled trials assessing the effects of fluoxetine on weight and metabolic parameters in T2DM patients.

Potential Biases

Potential selection bias due to the exclusion of non-compliant participants and lack of detailed reporting on randomization and allocation concealment.

Limitations

The studies included varied in follow-up duration and participant demographics, and some studies had unclear randomization methods.

Participant Demographics

Participants were generally middle-aged individuals with type 2 diabetes, with a mix of genders.

Statistical Information

P-Value

p<0.00001

Confidence Interval

95%CI 2.58–5.97

Statistical Significance

p<0.00001

Digital Object Identifier (DOI)

10.1371/journal.pone.0021551

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication